Accustem Sciences - About the company
Accustem Sciences is a public company based in London (United Kingdom), founded in 2020. It operates as a Provider of innovative solutions and tools to improve outcomes for patients with cancer. Accustem Sciences has raised an undisclosed amount in funding. The company has 415 active competitors, including 26 funded and 45 that have exited. Its top competitors include companies like Sibel Health, Agiliti and TEAM Technologies.
Company Details
- Website
- accustem.com
- Email ID
- *****@accustem.com
Key Metrics
Founded Year
2020
Location
London, United Kingdom
Stage
Public
Latest Funding Round
Investors
Ranked
10th among 415 active competitors
Employee Count
7 as on Aug 31, 2026
Similar Companies
Exit Details
Public
Legal entities associated with Accustem Sciences
Accustem Sciences is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
ACCUSTEM SCIENCES INC. CIN: 1850767 , United States, Active | Jul 27, 2021 | - | - | - |
ACCUSTEM SCIENCES, INC. CIN: 87-3774438 , United States, Active | Mar 03, 2022 | - | - | - |
Accustem Sciences's IPO details
Accustem Sciences got listed on Mar 04, 2022.
Click here to take a look at Accustem Sciences's IPO in detail
Sign up to download Accustem Sciences' company profile
Accustem Sciences's funding and investors
Accustem Sciences has raised funding over 1 round. Its latest funding round was a Post IPO round on Apr 05, 2022 for $*****. 1 investor participated in its latest round. Accustem Sciences has 1 institutional investor.
Here is the list of recent funding rounds of Accustem Sciences:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 05, 2022 | 7019725 | Post IPO | 8727287 | 1831822 | 9406738 | 2474496 |
View details of Accustem Sciences's funding rounds and investors
Accustem Sciences' founders and board of directors
Founder? Claim ProfileAccustem Sciences' employee count trend
Accustem Sciences has 7 employees as of Aug 26. Here is Accustem Sciences's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Accustem Sciences's Competitors and alternates
Top competitors of Accustem Sciences include Sibel Health, Agiliti and TEAM Technologies. Here is the list of Top 10 competitors of Accustem Sciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Sibel Health 2018, Niles (United States), Series C | Developer of wireless medical monitoring devices for clinical and remote use | $71M | 63/100 | |
2nd | Agiliti 1939, Minneapolis (United States), Public | Provider of medical equipment management services | - | 53/100 | |
3rd | TEAM Technologies 1988, Morristown (United States), Acquired | Manufacturer of medical devices and dental products | - | 50/100 | |
4th | Provider of healthcare consulting, outsourced imaging, and managed equipment services | - | 45/100 | ||
5th | Affordable Care 1975, Morrisville (United States), Funding Raised | Provider of medical equipment support services | - | 42/100 | |
6th | Taewoong Medical 1991, Gimpo-si (South Korea), Acquired | Provider of medical equipment services | - | - | 40/100 |
7th | Provider of home healthcare products and services for patients and healthcare facilities | - | 37/100 | ||
8th | Tangent United States, Unfunded | Manufacturer of medical grade computers, industrial PCs, and related software solutions | - | - | 37/100 |
9th | Neola Medical 2016, Lund (Sweden), Funding Raised | Provider of NICU & lung monitoring units development services | - | - | 36/100 |
10th | Accustem Sciences 2020, London (United Kingdom), Public | Provider of innovative solutions and tools to improve outcomes for patients with cancer | - | 36/100 |
Looking for more details on Accustem Sciences's competitors? Click here to see the top ones
Accustem Sciences's Investments and acquisitions
Accustem Sciences has made no investments or acquisitions yet.
Reports related to Accustem Sciences
Here is the latest report on Accustem Sciences's geography:
News related to Accustem Sciences
•
AccuStem Sciences and EmeritusDX Expand Blood-Based Testing AccessibilityGlobeNewswire•Sep 17, 2025•Accustem Sciences, EmeritusDX
•
AccuStem Sciences Chairman Gabriele Cerrone buys additional 8,991 shares
Seeking Alpha•Jun 13, 2025•Accustem Sciences
•
AccuStem Sciences and EmeritusDX Partner to Commercialize Lung Cancer Screening TestGlobeNewswire•Apr 28, 2025•Accustem Sciences, EmeritusDX
•
•
AccuStem Sciences Signs Agreement to Access Blood Samples for Lung Cancer ResearchGlobeNewswire•Apr 16, 2025•Accustem Sciences
•
AccuStem to Offer MSC Blood Test for Lung Cancer Screening in the USGlobeNewswire•Apr 04, 2025•Accustem Sciences
•
AccuStem Sciences acquires licence for lung cancer screening testMedicalDeviceNetwork•Mar 19, 2025•Accustem Sciences
•
AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening TestGlobeNewswire•Mar 18, 2025•Accustem Sciences, Sitexinc
•
•
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic PartnershipGlobeNewswire•Jul 17, 2023•EmeritusDX, Accustem Sciences
Are you a Founder ?
FAQs about Accustem Sciences
Explore our recently published companies
- Liz Ahrens - Unfunded company
- Dialer Guru - Germany based, Unfunded company
- Imergence - New York City based, 2011 founded, Unfunded company
- Sud Informatique - France based, 2003 founded, Unfunded company
- Raphael Henri Medium - France based, Unfunded company
- Newcastle - Unfunded company
